Skip to main content

Heart Diseases clinical trials at UCSD
2 in progress, 1 open to new patients

  • TandemHeart Experiences and MEthods (THEME Registry)

    open to eligible people ages 18 years and up

    This study is intended to be a multicenter, prospective observation registry. By collecting prospective descriptive data, provide insight into disease defining characteristics resulting in the clinical decision to use TandemHeart for mechanical support and enhance knowledge of best practice regarding clinical management, weaning and removal/exit strategies.

    La Jolla, California and other locations

  • Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease

    Sorry, not yet accepting patients

    Treatment for no-option heart patients with coronary artery disease. Procedure includes the injection into the heart of a protein growth factor, administered by the Cordis Corp. MyoStar injection catheter, to stimulate the growth of blood vessels around blocked coronary arteries.

    San Diego, California and other locations